Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
CBG-MEB · 82 medicines
Health Canada · 59 medicines
AIFA · 46 medicines
SFDA · 34 medicines · Historical list
MS · 25 medicines · Historical list
HSA · 20 medicines
FDA · 20 medicines
PHARMAC · 12 medicines
ALIMS · 11 medicines
HALMED · 8 medicines
ANMAT · 2 medicines · Historical list
EMA · 1 medicine · Historical list
Show all 1Every register, a page at a time. Strengths and packs are on each medicine’s page.
21 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Omeprazole | United States | 20MG | tablet, delayed release | Marketed | Apotex |
| Omeprazole | United States | 20MG | tablet, orally disintegrating, delayed release | Marketed | Dexcel |
| Omeprazole | United States | 10MG, 20MG, 40MG | capsule, delayed rel pellets | Marketed | Xiromed |
| Omeprazole Magnesium | United States | 20MG BASE | tablet, delayed release | Marketed | Hetero Labs LTD III |
| Omeprazole Magnesium | United States | 20MG BASE | capsule, delayed release | Marketed | Dexcel |
| Omeprazole and Sodium BicarbonateCombination | United States | 20MG/PACKET; 1.68GM/PACKET, 40MG/PACKET; 1.68GM/PACKET | for suspension | Marketed | Novitium Pharma |
| Omeprazole and Sodium BicarbonateCombination | United States | 20MG; 1.1GM, 40MG; 1.1GM | capsule | Marketed | Zydus Pharms |
| KonvomepCombination | United States | 2MG/ML; 84MG/ML | for suspension | Marketed | Azurity |
| Zegerid OTCCombination | United States | 20MG; 1.1GM | capsule | Marketed | Riley Consumer |
| Prilosec OTC | United States | 20MG BASE | tablet, delayed release | Marketed | Astrazeneca |
| Magnesium Hydroxide and Omeprazole and Sodium BicarbonateCombination | United States | 343MG; 20MG; 750MG, 343MG; 40MG; 750MG | tablet | Not marketed | Santarus |
| Zegerid OTCCombination | United States | 20MG/PACKET; 1.68GM/PACKET | for suspension | Marketed | Riley Consumer |
| Aspirin; OmeprazoleCombination | United States | 325MG; 40MG, 81MG; 40MG | tablet | Tentative approval | Teva Pharms USA INC |
| Prilosec | United States | 10MG BASE/PACKET, 2.5MG BASE/PACKET | for suspension, delayed release | Marketed | Azurity |
| ZegeridCombination | United States | 20MG; 1.1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 40MG; 1.1GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule | Not marketed | Salix |
| ZegeridCombination | United States | 20MG/PACKET; 1.68GM/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 40MG/PACKET; 1.68GM/PACKET, 40MG/PACKET; 1.68GM/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | for suspension | Not marketed | Santarus |
| Prilosec | United States | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule, delayed rel pellets | Not marketed | Astrazeneca |
| TaliciaCombination | United States | 250MG; 10MG BASE; 12.5MG | capsule, delayed release | Marketed | Talicia Holdings |
| YospralaCombination | United States | 325MG; 40MG, 81MG; 40MG | tablet, delayed release | Not marketed | Genus Lifesciences |
| ZegeridCombination | United States | 700MG; 20MG; 600MG, 700MG; 40MG; 600MG | tablet, chewable | Not marketed | Santarus |
| Omeclamox-PakCombination | United States | 500MG,N/A,N/A; 500MG,N/A; 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule, tablet, capsule, delayed release | Not marketed | Cumberland |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, ANMAT, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS, PHARMAC and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
